penetrating keratoplasty
Showing 1 - 5 of 5
DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract
Completed
- Anterior Chamber Inflammation
- +7 more
- Dextenza 0.4Mg Ophthalmic Insert
-
Los Angeles, CaliforniaAdvanced Vision Care
Jul 14, 2021
Corneal Edema, Corneal Defect, Corneal Transplant Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate
Recruiting
- Corneal Edema
- +5 more
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Los Angeles, CaliforniaAdvanced Vision Care
Dec 23, 2020
Corneal Epithelial Defect, Diabetic Retinopathy, Penetrating Keratoplasty Trial in Taipei (autologous serum, Non-autologous
Completed
- Corneal Epithelial Defect
- +2 more
- autologous serum
- Non-autologous serum
-
Taipei, TaiwanNational Taiwan University Hospital, department of Ophthalmology
Sep 7, 2010
Lipid Keratopathy, Penetrating Keratoplasty, Herpetic Keratopathy Trial in Taipei (subconjunctival injection of bevacizumab (
Completed
- Lipid Keratopathy
- +3 more
- subconjunctival injection of bevacizumab ( 1.25 to 2.50 mg)
-
Taipei, TaiwanDepartment of Ophthalmology, National Taiwan University Hospital
May 20, 2008
Penetrating Keratoplasty Trial (FK506 0.06% (eye drops))
Terminated
- Penetrating Keratoplasty
- FK506 0.06% (eye drops)
- (no location specified)
Apr 18, 2007